Summary:
- The article discusses the rise and fall of artificial intelligence (AI) companies that focused on pathology, which is the study of diseases.
- These AI companies aimed to use machine learning algorithms to analyze medical images, such as tissue samples, to help doctors diagnose diseases more accurately and efficiently.
- However, many of these AI pathology companies have struggled or shut down, facing challenges such as regulatory hurdles, difficulty integrating with existing healthcare systems, and the complexity of the medical field.